This cluster is noise. The $592K in sales is trivial for a $57B company and likely reflects routine diversification or tax planning. No trading signal. Monitor for any material insider buying (which would be a stronger signal) or a change in the pattern of sales, but this filing alone warrants no action.
TAK drugs
TAK drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 20 $18.13entry
- T+1 · 3mo ago +0.28%α −0.13% · $18.18
- T+5 · 3mo ago −0.55%α −1.67% · $18.03
- T+20 · 2mo ago +4.30%α +4.42% · $18.91
- T+60 · 4d ago +18.20%α +19.28% · $21.43
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Takeda insiders, the President of Global Supply & Quality and the Chief Human Resources Officer, sold a combined $592K in open-market sales over an 8-day window. The total value is ~0.001% of Takeda's $57B market cap, making this a trivial, routine cluster with no material signal. The sales are likely liquidity-driven (vesting/blackout window) and do not indicate a bearish view on the company's fundamentals, especially given the strong analyst consensus (67% bullish) and the company's large cap.
Key Financial Metrics
Key Facts
- Two insiders sold a total of ~33,400 shares for ~$592K in open-market transactions between Aug 11 and Aug 18, 2026.
- The total sale value is approximately 0.001% of Takeda's $57B market cap, well below the 0.1% threshold for materiality.
- Both sellers are senior executives (President of Global Supply & Quality and Chief Human Resources Officer), but the dollar amounts are immaterial.
- No insider buying was detected in the cluster; the net direction is selling, but the scale is trivial.
- The 30-day trailing insider activity shows $6.8M in total sales, consistent with routine portfolio management at a mega-cap pharma.
Financial Impact
Total insider sales of ~$592K, representing ~0.001% of market cap, immaterial.
Risk Factors
- Insider sales could accelerate if management sees headwinds, but current volume is too small to indicate anything.
- No risk from this filing, the cluster is immaterial in size.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TAK-1787196903890 |
Track record
18 reports on TAK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 29, 202618d ago 6-K Neutral 4/10 No price data
- Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
- Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Viewing Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
- Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers